Xie Zhangjuan, Xia Jie, Jiao Mengxia, Zhao Pengyuan, Wang Zhiqiang, Lin Shengli, Xing Yun, Li Yifan, Lu Zhou, Zhong Ziwen, Miao Changhong, Zhou Pinghong, Qian Jiawen, Wang Luman, Zhang Dan, Gu Jie, Chu Yiwei, Liu Ronghua
Shanghai Fifth People's Hospital, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Shanghai Fifth People's Hospital, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China; Department of Immunology, School of Basic Medical Sciences and Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.
Biochem Biophys Res Commun. 2023 Feb 12;644:112-121. doi: 10.1016/j.bbrc.2023.01.005. Epub 2023 Jan 6.
Regulatory B cells (Bregs) contribute to tumor immunosuppression. However, how B cells acquire their regulatory features in tumors remain unclear. Exosomes are important messengers that transmit tumor information to remodel tumor immunity. Here we revealed that tumor-derived exosomes drive Bregs to suppress anti-tumor immunity by delivering long non-coding RNAs (lncRNAs). HOTAIR was screened by lncRNA profiling in both colorectal cancer (CRC)-derived exosomes and infiltrating B cells. Tumor-derived HOTAIR polarized B cells toward a regulatory feature marked by programmed cell death-ligand 1 (PDL1) in CRC, and induced PDL1 B cells to suppress CD8 T cell activity. Exosomal HOTAIR bound to and protected pyruvate kinase M2 (PKM2) against ubiquitination degradation, resulting in STAT3 activation and PDL1 expression. Results from CRC patients showed a positive correlation between exosomal HOTAIR and tumor-infiltrating PDL1 B cells. These findings reveal how B cells acquire PDL1-dominant regulatory feature in CRC, implying the clinical significance of exosomal therapy targeting HOTAIR.
调节性B细胞(Bregs)有助于肿瘤免疫抑制。然而,B细胞如何在肿瘤中获得其调节特性仍不清楚。外泌体是传递肿瘤信息以重塑肿瘤免疫的重要信使。在这里,我们揭示了肿瘤来源的外泌体通过传递长链非编码RNA(lncRNAs)来驱动Bregs抑制抗肿瘤免疫。通过lncRNA谱分析在结直肠癌(CRC)来源的外泌体和浸润性B细胞中筛选出HOTAIR。肿瘤来源的HOTAIR使CRC中的B细胞向以程序性细胞死亡配体1(PDL1)为特征的调节特性极化,并诱导PDL1+B细胞抑制CD8+T细胞活性。外泌体HOTAIR与丙酮酸激酶M2(PKM2)结合并保护其免受泛素化降解,导致STAT3激活和PDL1表达。CRC患者的结果显示外泌体HOTAIR与肿瘤浸润性PDL1+B细胞之间呈正相关。这些发现揭示了B细胞如何在CRC中获得以PDL1为主的调节特性,暗示了针对HOTAIR的外泌体疗法的临床意义。